2-(13Z-docosenoyl)-sn-glycero-3-phosphoethanolamine

Metabolite details

Identifier

LKQYAECRDPDYTP-RASRKNKNSA-N

InChI Key

LKQYAECRDPDYTP-RASRKNKNSA-N

IUPAC name

Preferred name

2-(13Z-docosenoyl)-sn-glycero-3-phosphoethanolamine

INN name

—

Synonym

(2-aminoethoxy)[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-hydroxypropoxy]phosphinic acid

ChEBI

CHEBI:138522

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Control_vs_OXPA_Treatment
• Control_12h_vs_Toxocara canis_12h
• Normal_vs_Neural_Tube_Defect
• Male_19_days_vs_Male_1_day
• Knockdown_vs_Control
• Knockdown_vs_Control